comparemela.com

Latest Breaking News On - Evolent health stock - Page 1 : comparemela.com

Canaccord Genuity Group Lowers Evolent Health (NYSE:EVH) Price Target to $44 00

Evolent Health (NYSE:EVH – Free Report) had its target price cut by Canaccord Genuity Group from $45.00 to $44.00 in a research report report published on Thursday, Benzinga reports. They currently have a buy rating on the technology company’s stock. A number of other equities analysts have also issued reports on the company. Oppenheimer assumed […]

Evolent Health (NYSE:EVH) Shares Gap Up to $29 77

Evolent Health, Inc. (NYSE:EVH – Get Free Report)’s stock price gapped up before the market opened on Friday . The stock had previously closed at $29.77, but opened at $32.75. Evolent Health shares last traded at $31.81, with a volume of 258,344 shares trading hands. Wall Street Analyst Weigh In Several research firms recently weighed […]

Premier Fund Managers Ltd Sells 13,310 Shares of Evolent Health, Inc (NYSE:EVH)

Premier Fund Managers Ltd Sells 13,310 Shares of Evolent Health, Inc (NYSE:EVH)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Brokerages Set Evolent Health, Inc (NYSE:EVH) Target Price at $46 56

Shares of Evolent Health, Inc. (NYSE:EVH – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eight brokerages that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month […]

Evolent Health, Inc (NYSE:EVH) Receives $46 56 Average PT from Analysts

Shares of Evolent Health, Inc. (NYSE:EVH – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eight research firms that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.